Careers  |  Sign In  |  Register  |   Twitter

Latest in Pathology & Lab Medicine

There have been many advancements in chemotherapy and immunotherapy treatments for various cancers over the past decade, but the 5-year relative survival rate for glioblastoma patients is still around 10%. Since glioblastoma is a rare condition, an RO-1 grant from the FDA has been awarded to GenSpera, Inc....
A new method of coaxing adult cells into iMS cells may be safer, more versatile, and more effective than current, experimental embryonic stem cell processes.
Prospective or expecting parents have options when trying to determine their baby's risk of being born with certain genetic conditions.